Cargando…

Platelet Dysfunction in Thrombosis Patients Treated with Vitamin K Antagonists and Recurrent Bleeding

BACKGROUND: Recurrent bleeding can complicate the treatment of thrombosis patients with vitamin K antagonists (VKA), even at a well-regulated level of anticoagulation. In this proof-of-principle study, we investigated whether alterations in platelet function or von Willebrand factor (vWf) contribute...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Meijden, Paola E. J., Bouman, Annemieke C., Feijge, Marion A. H., van Oerle, René, Spronk, Henri M. H., Hamulyák, Karly, ten Cate-Hoek, Arina J., ten Cate, Hugo, Heemskerk, Johan W. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665853/ https://www.ncbi.nlm.nih.gov/pubmed/23724024 http://dx.doi.org/10.1371/journal.pone.0064112

Ejemplares similares

Postoperative thromboembolic prophylaxis in joint replacement surgery: Guidelines and daily practice
por: ten Cate-Hoek, Arina J, et al.
Publicado: (2012)

Clonal hematopoietic mutations linked to platelet traits and the risk of thrombosis or bleeding
por: Veninga, Alicia, et al.
Publicado: (2020)

Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease
por: Olie, Renske H., et al.
Publicado: (2019)

Searching for a Common Thrombo-Inflammatory Basis in Patients With Deep Vein Thrombosis or Peripheral Artery Disease
por: Kremers, Bram M. M., et al.
Publicado: (2019)

A new method to determine tissue specific tissue factor thrombomodulin activities: endotoxin and particulate air pollution induced disbalance
por: Frederix, Kim, et al.
Publicado: (2008)

Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing
por: Bloemen, Saartje, et al.
Publicado: (2017)

The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial
por: ten Cate-Hoek, Arina J, et al.
Publicado: (2014)

The hypercoagulable profile of patients with stent thrombosis
por: Loeffen, R, et al.
Publicado: (2015)

Postinterventional antithrombotic management after venous stenting of the iliofemoral tract in acute and chronic thrombosis: A systematic review
por: Notten, Pascale, et al.
Publicado: (2021)

Plasma Biomarkers to Predict Cardiovascular Outcome in Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis
por: Kremers, Bram, et al.
Publicado: (2020)

Risk factors for recurrence in deep vein thrombosis patients following a tailored anticoagulant treatment incorporating residual vein obstruction
por: Nagler, Michael, et al.
Publicado: (2018)

Evaluation of the analytical performance of the PC100 platelet counter
por: Nagy, Magdolna, et al.
Publicado: (2021)

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
por: Henskens, Yvonne M. C., et al.
Publicado: (2018)

Budget Impact of Three Improvement Targets for Compression Therapy for Patients with Deep Venous Thrombosis in The Netherlands
por: Schreurs, Rachel H. P., et al.
Publicado: (2023)

Key role of integrin α(IIb)β(3) signaling to Syk kinase in tissue factor-induced thrombin generation
por: van der Meijden, Paola E. J., et al.
Publicado: (2012)

Predicting Recurrent Venous Thromboembolism in Patients With Deep-Vein Thrombosis: Development and Internal Validation of a Potential New Prediction Model (Continu-8)
por: Nagler, Michael, et al.
Publicado: (2021)

Calibrated Automated Thrombinography (CAT), a Tool to Identify Patients at Risk of Bleeding during Anticoagulant Therapy: A Systematic Review
por: Zwaveling, Suzanne, et al.
Publicado: (2018)

Development of a Consensus-Based Cross-Domain Protocol for the Management of Elastic Compression Stocking Therapy in Patients With Deep Venous Thrombosis and Chronic Venous Disease: A Modified Delphi Study
por: Schreurs, Rachel H. P., et al.
Publicado: (2022)

Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
por: Grottke, Oliver, et al.
Publicado: (2013)

Quality of anticoagulant therapy and the incidence of in‐stent thrombosis after venous stenting
por: Notten, Pascale, et al.
Publicado: (2020)

A realist evaluation to identify targets to improve the organization of compression therapy for deep venous thrombosis- and chronic venous disease patients
por: Schreurs, Rachel H. P., et al.
Publicado: (2022)

Residual Venous Obstruction as an Indicator of Clinical Outcomes following Deep Vein Thrombosis: A Management Study
por: Iding, Aaron F. J., et al.
Publicado: (2023)

Prevention and treatment of the post‐thrombotic syndrome
por: ten Cate‐Hoek, Arina J.
Publicado: (2018)

The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study
por: Gulpen, Anouk J. W., et al.
Publicado: (2019)

Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
por: Kleinegris, Marie-Claire F., et al.
Publicado: (2017)

Clinical Applications, Pitfalls, and Uncertainties of Thrombin Generation in the Presence of Platelets
por: Panova-Noeva, Marina, et al.
Publicado: (2019)

Thrombin–Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Prevalence of venous obstructions in (recurrent) venous thromboembolism: a case-control study
por: Notten, Pascale, et al.
Publicado: (2020)

Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes
por: Sommeijer, Dirkje W, et al.
Publicado: (2005)

Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events
por: Loeffen, Rinske, et al.
Publicado: (2016)

P1647: CHRONIC INFLAMMATORY DISEASES INCREASE THE RISK OF POST-THROMBOTIC SYNDROME: A PROSPECTIVE COHORT STUDY
por: Iding, Aaron F.J., et al.
Publicado: (2023)

Potential value of the calibrated automated thrombogram in patients after a cerebral venous sinus thrombosis; an exploratory study
por: van der Bruggen, Myrthe M., et al.
Publicado: (2021)

Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
por: Honickel, M, et al.
Publicado: (2014)

Preoperative screening for bleeding disorders: A comprehensive laboratory assessment of clinical practice
por: Vries, Minka J., et al.
Publicado: (2018)

Using the Functional Resonance Analysis Method to explore how elastic compression therapy is organised and could be improved from a multistakeholder perspective
por: Schreurs, Rachel Hellen Petra, et al.
Publicado: (2021)

Thrombosis: Grand Challenges Ahead!
por: ten Cate, Hugo
Publicado: (2021)

Editorial: Insights in thrombosis: 2021
por: ten Cate, Hugo
Publicado: (2022)

Thrombin Generation in the Glasgow Myocardial Infarction Study
por: Smid, Machiel, et al.
Publicado: (2013)

Integrating platelet and coagulation activation in fibrin clot formation
por: Swieringa, Frauke, et al.
Publicado: (2018)

Calibrated automated thrombogram II: removing barriers for thrombin generation measurements
por: Giesen, P. L. A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7d2j739366rut3ahslpj8kfc9d